Trilinolein [537-40-6]
Referência HY-128393-1mL
Tamanho : 10mM/1mL
Marca : MedChemExpress
| Description |
Trilinolein is an orally active triglyceride that inhibits the PI3K/Akt, Ras/MEK/ERK signaling pathways, and MMP-2. Trilinolein can reduce oxidative stress, induce apoptosis, and inhibit cell migration. Trilinolein can be used in the research fields of cardiovascular disease, cerebrovascular disease (such as cerebral ischemia), and non-small cell lung cancer[1][2][3]. |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IC50 & Target |
|
||||||||||||
| In Vitro |
Trilinolein (10 μM; 24 h) can increase the cell viability of endothelial cells stimulated by ox-LDL (HY-NP135), reduce apoptosis, inhibit ICAM-1 and E-selectin mRNA expression, and enhance antioxidant activity (increased SOD and GPX, decreased MDA)[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
|
||||||||||||
| In Vivo |
Trilinolein (50, 100, 200 mg/kg; oral; single dose; 1 hour before ischemia, 24 hours after reperfusion) can reduce cerebral infarction area, neurological deficits and TUNEL-positive neuronal apoptosis in the Sprague-Dawley rat model of cerebral ischemia-reperfusion[3]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
|
||||||||||||
| Essai clinique |
|
||||||||||||
| Masse moléculaire |
879.38 |
||||||||||||
| Formule |
C57H98O6 |
||||||||||||
| CAS No. | |||||||||||||
| Appearance |
Liquid (Density: 0.9184 g/cm3) |
||||||||||||
| Color |
Colorless to light yellow |
||||||||||||
| SMILES |
CCCCC/C=C\C/C=C\CCCCCCCC(OCC(OC(CCCCCCC/C=C\C/C=C\CCCCC)=O)COC(CCCCCCC/C=C\C/C=C\CCCCC)=O)=O |
||||||||||||
| Structure Classification | |||||||||||||
| Initial Source | |||||||||||||
| Livraison | Room temperature in continental US; may vary elsewhere. |
||||||||||||
| Stockage |
-20°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
||||||||||||
| Solvant et solubilité |
In Vitro:
DMSO : 100 mg/mL (113.72 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) Preparing
Stock Solutions
View the Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles. Select the appropriate dissolution method based on your experimental animal and administration route.
For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
|
||||||||||||
| Pureté et documentation | |||||||||||||
| Références |
|

